DICE Therapeutics, Inc. financial data

Location
400 East Jamie Court, Suite 300, South San Francisco, CA
Fiscal year end
December 30
Latest financial report
10-Q - Q2 2023 - Aug 8, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3K % +20.4%
Debt-to-equity 5.87 % -12.9%
Return On Equity -22 % +9.31%
Return On Assets -20.8 % +8.58%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47.8M shares +25.1%
Common Stock, Value, Issued 5K USD +25%
Weighted Average Number of Shares Outstanding, Basic 47.3M shares +26.6%
Weighted Average Number of Shares Outstanding, Diluted 47.3M shares +26.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 86.7M USD +67.8%
General and Administrative Expense 32M USD +50.3%
Operating Income (Loss) -119M USD -62.7%
Net Income (Loss) Attributable to Parent -104M USD -41.5%
Earnings Per Share, Basic -2 USD/shares -27.6%
Earnings Per Share, Diluted -2 USD/shares -27.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 73.5M USD +338%
Marketable Securities, Current 455M USD +71.4%
Assets, Current 532M USD +86.9%
Property, Plant and Equipment, Net 4.44M USD +42.7%
Operating Lease, Right-of-Use Asset 12.3M USD -11%
Other Assets, Noncurrent 1.42M USD +156%
Assets 551M USD +82%
Accounts Payable, Current 3.41M USD +73.9%
Liabilities, Current 20.6M USD +70.5%
Operating Lease, Liability, Noncurrent 11M USD -12.2%
Liabilities 31.6M USD +28.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2K USD
Retained Earnings (Accumulated Deficit) -248M USD -72.5%
Stockholders' Equity Attributable to Parent 519M USD +86.8%
Liabilities and Equity 551M USD +82%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.4M USD -58.4%
Net Cash Provided by (Used in) Financing Activities 292K USD
Net Cash Provided by (Used in) Investing Activities -338M USD -605%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 73.7M USD +334%
Depreciation 244K USD +61.6%
Payments to Acquire Property, Plant, and Equipment 202K USD -47.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -103M USD -36.5%
Operating Lease, Liability, Current 1.53M USD +16.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 767M USD +81.2%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 4.39M USD -16.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%